Effect of the mGluR5-NAM Basimglurant on Behavior in Adolescents and Adults with Fragile X Syndrome in a Randomized, Double-Blind, Placebo-Controlled Trial: FragXis Phase 2 Results. (Record no. 27473507)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02400 a2200613 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517170820.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201811s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1740-634X |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1038/npp.2017.177 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Youssef, Eriene A |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20181120 |
245 00 - TITLE STATEMENT | |
Title | Effect of the mGluR5-NAM Basimglurant on Behavior in Adolescents and Adults with Fragile X Syndrome in a Randomized, Double-Blind, Placebo-Controlled Trial: FragXis Phase 2 Results. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology |
Date of publication, distribution, etc. | 02 2018 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 503-512 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adolescent |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | DNA Methylation |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Double-Blind Method |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Excitatory Amino Acid Antagonists |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Fragile X Mental Retardation Protein |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Fragile X Syndrome |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Imidazoles |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Psychotropic Drugs |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pyridines |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | RNA, Messenger |
General subdivision | blood |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Receptor, Metabotropic Glutamate 5 |
General subdivision | antagonists & inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Treatment Failure |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Young Adult |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Berry-Kravis, Elizabeth |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Czech, Christian |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hagerman, Randi J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hessl, David |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Wong, Chin Y |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Rabbia, Michael |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Deptula, Dennis |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | John, Amy |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kinch, Russell |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Drewitt, Philip |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lindemann, Lothar |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Marcinowski, Moritz |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Langland, Rachel |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Horn, Carsten |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Fontoura, Paulo |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Santarelli, Luca |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Quiroz, Jorge A |
773 0# - HOST ITEM ENTRY | |
Title | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology |
Related parts | vol. 43 |
-- | no. 3 |
-- | p. 503-512 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1038/npp.2017.177">https://doi.org/10.1038/npp.2017.177</a> |
Public note | Available from publisher's website |
No items available.